Ligand ID: LUR

Drugbank ID:
Lumiracoxib
(DB01283)


Indication:
Lumiracoxib is a COX-2 selective non-steroidal anti-inflammatory drug (NSAID). On August 11, 2007, Australia's Therapeutic Goods Administration (TGA, the Australian equivalent of the FDA) cancelled the registration of lumiracoxib in...


LIST OF BINDING INTERFACES for query 'LUR'

(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
(Click on the 'View' column to view patterns on the structural viewer)

DrReposER ID PDB Ligand Drug Organism Macromolecule Pfam Res. Interface HETATM View Details
4IK6_A_LURA2014ik6 LURLumiracoxib
(DB01283)
Homo sapiens TRANSTHYRETIN Transthyretin 5LYS A  15
LEU A  17
THR A 106
ALA A 108
VAL A 121
LUR A 201
4OTY_A_LURA7054oty LURLumiracoxib
(DB01283)
Mus musculus PROSTAGLANDIN G/H SYNTHASE 2 An_peroxidase
EGF
17PHE A 205
TYR A 348
VAL A 349
LEU A 352
SER A 353
TYR A 355
PHE A 381
LEU A 384
TYR A 385
TRP A 387
PHE A 518
MET A 522
VAL A 523
GLY A 526
ALA A 527
SER A 530
LEU A 531
LUR A 705
DrReposER ID PDB Ligand Drug Organism Macromolecule Pfam Res. Interface HETATM View Details